IDO1 and colorectal carcinoma: In the CRC TME, malignant cells, TAMs, MDSCs inhibitory DCs, and cancer-associated fibroblasts markedly overexpress indoleamine 2,3-dioxygenase (IDO), the rate-limiting enzyme of Trp catabolism (283, 284).